How does ruxolitinib compare to topical corticosteroids and topical calcineurin inhibitors for vitiligo?Featuring Neal Bhatia, MD | Director of Clinical DermatologyTherapeutics Clinical ResearchSan Diego, CA | Published March 03, 2025Loading...Related CMEView allRelated MediaPowered by Polaris TM